Sign in

Narjust Florez, MD, FASCO

@narjustflorezmd.bsky.social
690 followers 352 following 121 posts

Assc. Director CCEP & Thoracic Oncologist @DanaFarberNews & @Harvardmed| Young Lung Cancer | Editor @Jamaonc | Co-founder @LatinasInMed | @Florez_Lab

PostsRepliesMedia
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 21/05/2025
In the ER with dad, I went to the bathroom and a code was called, I have never prayed so hard not to hear the number 82
010
Reposted by Narjust Florez, MD, FASCO
Gravel Influencer @gravelinfluencer.bsky.social · 16/05/2025
From @hsph.harvard.edu on Instagram. In FY 25, 46% of the school's budget came from federal grants. Thinking of the many friends I have at Harvard Chan right now who just want to do work that will make the world healthier.

Yesterday afternoon, scientists across Harvard Chan School learned the government had abruptly terminated their research.
Nearly every single one of the school's direct federal grants was terminated.
132 100 173
HARVARD T.H. CHAN
SCHOOL OF PUBLIC HEALTH
324499
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 17/05/2025
Honored to receive this recognition by Leaders in Healthcare as the 2025 Rising Star Woman in Healthcare. Gracias Totales!
020
Reposted by Narjust Florez, MD, FASCO
Florez Lab @florezlab.bsky.social · 16/05/2025
✨ It’s so shiny we can’t stop staring or taking📸👀🌟 @narjustflorezmd.bsky.social Rising Star Women Leader in Healthcare Award just arrived and it’s giving serious disco ball energy 💃🏽💫 (just like her plant hehe✨)
111
Reposted by Narjust Florez, MD, FASCO
The Cancer Letter @cancerletter.com · 17/05/2025
Tom Lynch (@fredhutch.bsky.social) and Skip Burris (@scri.com) on how NIH funding cuts imperil biopharma innovation—and cost patient lives. In a time of uncertainty, “react to the knowns, not the fear” cancerletter.com/podcastc/20250516_1
cancerletter.com
The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives In a time of uncertainty, “react to the knowns, not the fear”...
Thomas J. Lynch Jr. and Howard A. “Skip” Burris III lead two institutions that couldn’t be more different—an NCI-designated Comprehensive Cancer Center on one side of the country and a for-profit research enterprise on the other—but they stay up at nights worrying about the same thing: “Changing the paradigm of how research is funded and […]
041
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 17/05/2025
Humans are built resilient and some decide to use their struggles to excel Each time I visit “La Casa Azul” - Frida Kahlo’s house, I am reminded that I can find joy during the dark days & dare to be my true self
000
Reposted by Narjust Florez, MD, FASCO
Lung Cancer Research Foundation @lcrf.org · 28/04/2025
Women have unique challenges when facing a #LungCancer diagnosis. Drs. Narjust Florez and Isabel Preeshagul will address them during our May 14 Together Separately livestream, Women and Lung Cancer. Join us at 4 pm ET - sign up at LCRF.org/together. #WomenLC @narjustflorezmd.bsky.social
lcrf.org
Together Separately: Women and Lung Cancer - Lung Cancer Research Foundation
Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and thoracic medical oncologist at Dana-Farber Brigham Cancer Center, will join us once again for our popular Women and […]
071
Reposted by Narjust Florez, MD, FASCO
IASLC @iaslc.bsky.social · 29/04/2025
On #LungCancerConsidered this week, @narjustflorezmd.bsky.social & Dr. Mihaela Aldea talk about RET-positive NSCLC: diagnostic hurdles, treatment choices & more! 🎧 Tune in: bit.ly/TL25RET #TexasLung25 #NSCLC
bit.ly
What You Should Know About RET-Positive NSCLC: Live from TexasLung25 | IASLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Aldea about th ...
022
Reposted by Narjust Florez, MD, FASCO
Yvonne Diaz @yvonnediaz.bsky.social · 06/05/2025
Dr @narjustflorezmd.bsky.social doesn’t shy away from tough, taboo topics. @lungevity.bsky.social #HopeSummit, she led a powerful convo on how cancer affects identity, relationships, intimacy & sexual health. Her message: you deserve care, pleasure & to feel whole. Great party favours #LCSM
Five female lung Cancer Patient Advocates with leading thoracic oncologist, Dr Narjust Florez
Photo of Yvonne Diaz, lung Cancer Patient Advocate with leading thoracic oncologist, Dr Narjust Florez
061
Reposted by Narjust Florez, MD, FASCO
Latinasinmedicine @latinasinmed.bsky.social · 09/05/2025
Dra. @narjustflorezmd.bsky.social D es la líder que necesitamos en la Junta Directiva de la IASLC. Visionaria. Inclusiva. Valiente. ¿Necesitas más razones para votar por la Dra. Flórez? ✔️ Tiene una visión clara ✔️ Toma acción ✔️ Tiene un historial de impacto
111
Reposted by Narjust Florez, MD, FASCO
Florez Lab @florezlab.bsky.social · 09/05/2025
🎙 Together, Separately: Lung Cancer & Women Join @narjustflorezmd.bsky.social & Dr. Preeshagul in an important conversation on lung cancer and women’s health. 🗓 May 14 🕓 4 PM – 5:00 PM (ET) 📍 Don’t miss this powerful dialogue on disparities, advocacy, and change. #HearHer lcrf.org/together
lcrf.org
Together Separately: Women and Lung Cancer - Lung Cancer Research Foundation
Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and thoracic medical oncologist at Dana-Farber Brigham Cancer Center, will join us once again for our popular Women and […]
021
Reposted by Narjust Florez, MD, FASCO
Dana-Farber News @danafarbernews.bsky.social · 13/05/2025
Years after @ascocancer.bsky.social adopted respectful language guidelines, a study shows noncompliance is widespread. Speaking with @oncologynews.bsky.social, coauthor @narjustflorezmd.bsky.social @danafarber.bsky.social continues pushing for change in how patients are spoken about. bit.ly/3EQoBF5
bit.ly
ASCO Abstracts Show Persistent Noncompliance With Language of Respect Guidelines
Although ASCO adopted guidelines on using language of respect for patients and professionals in 2020, a recent study found that compliance is still sorely lacking.
054
Reposted by Narjust Florez, MD, FASCO
Florez Lab @florezlab.bsky.social · 14/05/2025
📢 That’s why we’re voting for Dr. @narjustflorezmd.bsky.social a trailblazer in research, mentorship, and global equity in cancer care. 📅 Don’t miss your chance to make an impact. 📩 Check your email for a ballot from noreply@directvote.net 🗓️ Deadline to vote: May 22
011
Reposted by Narjust Florez, MD, FASCO
Florez Lab @florezlab.bsky.social · 01/05/2025
New article alert!!!! @healthcentral.bsky.social Making Cancer Clinical Trials Work for Everyone, featuring commentary from @narjustflorezmd.bsky.social
111
Reposted by Narjust Florez, MD, FASCO
Dana-Farber News @danafarbernews.bsky.social · 25/04/2025
#AACR25 kicks off today and we’re proud to highlight exciting #headandneck, #breastcancer, #lungcancer and #cancersurvivorship research studies presented by @danafarber.bsky.social faculty. Check out the highlights here: bit.ly/4jLGH9Q
Dana-Farber faculty-led research at #AACR25
092
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 24/04/2025
From discussing young lung ca to the increasing incidence in women, the last 24 hrs in Cali, Colombia were full exchange of ideas Desde discusiones sobre el ca de pulmón en jóvenes hasta el aumento de casos en mujeres, las últimas 24 hrs en Cali, Colombia estuvieron llenas de intercambio de ideas
010
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 24/04/2025
Two great days in Medellin full of discussion about ALK + lung cancer and new friendships and collaborations. Dos días en Medellín llenos de discusiones sobre el cancer de pulmón ALK + y nuevas amistades y colaboraciones. Como decía Cerati - Gracias Totales!!
010
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 24/04/2025
As I reflect in the future, I realized the hard work and love we have put into the @IASLC podcast We extended our reach by introducing episodes in new languages Brought to stage early investigators from many regions Added discussions about sexual health, financial toxicity & more
140
Reposted by Narjust Florez, MD, FASCO
IASLC @iaslc.bsky.social · 22/04/2025
Live at #TexasLung25, @narjustflorezmd.bsky.social hosts Drs. Eric Singhi & Misty Shields on a new episode of #LungCancerConsidered for a talk on patient education & communication in oncology. 🎧 Listen now: bit.ly/TL25LCC #TexasLung25 #patientadvocacy #oncology
bit.ly
Excuse me, What? Top Recommendations for Effective Patient Communication in Oncology: Live from TexasLung25 | IASLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Eric Singhi and Dr. Mi ...
011
Reposted by Narjust Florez, MD, FASCO
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 19/04/2025
✅ Vote FLOREZ! Dr @narjustflorezmd.bsky.social Is running for the @iaslc.bsky.social Board of Directors. Her entire career has been dedicated to: 👉 Improving outcomes for people with #lungCancer 👉 Innovative research & ideas 👉 Strong mentorship to the next gen in #lcsm 🗳️ Undesignated Group # 4
ELECTION
TIME
VOTE FOR
DR. NARJUST FLOREZ
For The 2025 IASLC Undesignated
Board Seat #4
"Together we can make a difference!"
1114
Reposted by Narjust Florez, MD, FASCO
Toni Choueiri, MD @drchoueiri.bsky.social · 19/04/2025
Our own @danafarber.bsky.social Dr. @NarjustFlorezMD is running for @iaslc.bsky.social Board. Let us support NJ! @narjustflorezmd.bsky.social @danafarbernews.bsky.social
032
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 20/04/2025
From podcast host (since 2021) to 2024 WCLC Chair, it has been my honor to work with @IASLC to improve current practices, integrate new voices and bring patients to the forefront. And will continue with the same mission Election is open!
010
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 19/04/2025
Thank you! Your trust means so much! Undesignated seat #4
010
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 19/04/2025
Thank you friend - the sister that @ascocancer.bsky.social gifted me more than 10 years ago. Across a poster hall, I found a life-long friend. Please vote!
020
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 19/04/2025
Let’s do this team! 💪🏽
000
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 18/04/2025
Asking for your support as we try to make a difference TOGETHER!
000
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 18/04/2025
Story time about our EQUAL study - Reasons why we developed the largest @Florez_Lab study to date! If interested in participating and you are in New England - email us at equalstudy@dfci.harvard.edu
011
Reposted by Narjust Florez, MD, FASCO
IASLC @iaslc.bsky.social · 15/04/2025
On the new episode of #LungCancerConsidered @narjustflorezmd.bsky.social & Dr. Corey Langer discuss major updates from #ELCC25. These updates include MARIPOSA and ORCHARD & SOHO-01 trials, plus strategies to address treatment toxicity. 🎧 Listen here: bit.ly/LCC25ELCC #ELCC25
bit.ly
ELCC 2025: Insights and Review of the Data | IASLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez and Dr. Corey Langer discuss data presented at the recent European Lung Cancer Congress (ELCC ...
022
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 10/04/2025
I am gonna get real with y’all Wedding planning is fun and everything Until … They ask you what type of white you want?!? Like - how many types are they?
010
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 09/04/2025
Who qualifies for the EQUAL study? - early diagnosis of EGFR positive lung cancer You can reach us to equalstudy@dfci.harvard.edu
010
Reposted by Narjust Florez, MD, FASCO
Oncogene Cancer Research @oncogenecancer.bsky.social · 09/04/2025
Exciting to see the opening of the EQUAL study to see if we can diagnose EGFR & hopefully later other oncogene lung cancers earlier. We often don’t meet screening criteria & know that early detection saves lives. Find out more 👇 #lcsm
042
Reposted by Narjust Florez, MD, FASCO
Rheum Cat @rheumcat.bsky.social · 09/04/2025
I conceived this study in 2019, following the work of @narjustflorezmd.bsky.social and colleagues. We looked at whether there was gender bias in speaker introductions at the American College of Rheumatology (ACR) meeting. It's finally published - link.springer.com/article/10.1...
Rheumatology speaker introductions suggest gender bias: 
an evaluation of the 2022 American college of rheumatology 
convergence meeting

Abeera Azam 
Artem Minalyan
Noha Daher
Rahaf Baker
 Jean W. Liew
Vaneet K. Sandhu

Despite gender parity in the rheumatology workforce, biases may persist in speaker introductions at professional rheumatology meetings, as observed in other specialties. We analyzed speaker introductions at an international rheumatology 
conference to assess the relationship between speaker and moderator gender on professional address. We analyzed video-archived speaker introductions from the 2022 American College of Rheumatology (ACR) Convergence meeting. Two 
reviewers coded speaker and moderator gender and form of address. We defined a “strict address” as use of “Doctor” 
or “Professor” and “lenient address” as full name with a professional title. Fisher’s exact tests and logistic regression 
analyses examined associations between gender and forms of address. We analyzed 355 speakers (52.7% female, 47.3% 
male). Female speakers were less likely to receive a strict address by male moderators than male speakers (42.1% versus 
57.9%, χ2
=4.20, p=0.030). In logistic regression models after adjusting for moderator gender, male speakers were 1.8 
times more likely to receive a strict address versus female speakers [odds ratio (OR) 1.76; 95% confidence interval (CI) 
(1.10, 2.82)]. Male moderators were 64% less likely to provide a strict address than female moderators [OR 0.46; 95% 
CI (0.29, 0.73)], adjusting for speaker gender. At an international rheumatology meeting, male (versus female) speakers 
received formal introductions more frequently, and male (versus female) moderators were less likely to provide them. Our 
results suggest persistent gender bias in speaker introductions, highlighting a need for standardized practices for session 
moderators to improve gender equity
3162
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 09/04/2025
Our EQUAL study is open for enrollment! More in this video! @florezlab.bsky.social @latinasinmed.bsky.social
094
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 09/04/2025
We had a very special visitor at the @Florez_Lab today @LaurenMachos Friendship through different institutions and companies - many years and many more to come! Thank you for visiting us
020
Reposted by Narjust Florez, MD, FASCO
IASLC @iaslc.bsky.social · 25/03/2025
Did you catch the most recent episode of #LungCancerConsidered? @narjustflorezmd.bsky.social & @lauraaldermd.bsky.social dive into lung cancer & brain metastases—why MRI surveillance matters, how to time radiation & balancing risks like radiation necrosis. 🎧 Listen now: bit.ly/TTLC25LC-BM
bit.ly
Live from TTLC25: Lung Cancer and Brain Metastasis | IASLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses lung cancer and brain metastasis with Dr. Laura Alder.
073
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 25/03/2025
Join us this year walking to support our Young Lung Cancer Program at the 2025 @TheJimmyFund Walk You can: Donate Walk in person Walk virtually Register here: danafarber.jimmyfund.org/site/TR?fr_i...
030
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 22/03/2025
Mentorship meeting with Dr. @LauraAlderMD in Miami… I can get used to this Aims 1, 2, and 3 drafted Up to next ! 2025 @precisca Fellows Retreat
071
Reposted by Narjust Florez, MD, FASCO
Physicians for a Healthy Democracy @physiciandemocracy.medsky.social · 19/03/2025
No one tells Boston how to take care of our own.  Not kings, and not presidents who think they are kings.  Boston was born facing down bullies.
Mayor Wu, State of the City
12756128
Reposted by Narjust Florez, MD, FASCO
ALK Positive Lung Cancer UK @alkpositiveuk.bsky.social · 19/03/2025
The latest @iaslc.bsky.social Lung Cancer Considered podcast with @stephenvliu.bsky.social looks at treatment for Stage 3 ALK+ #lungcancer. This episode looks at a real case & the key decisions around treatment & molecular testing. 🎧 Listen here: www.iaslc.org/iaslc-news/l... #LSCM #ALKPositive
iaslc.org
Virtual Tumor Board: Stage III ALK+ NSCLC | IASLC
This IASLC Virtual Tumor Board episode focuses on a patient with stage III ALK-positive NSCLC. ALK fusions are present in about 5% of NSCLC and there are now si ...
071
Reposted by Narjust Florez, MD, FASCO
Latinasinmedicine @latinasinmed.bsky.social · 20/03/2025
Miren quien apareció en el periódico el JAYA, la doctora @narjustflorezmd.bsky.social!!!!! 📰 #ELJAYA #PeriodismoConHistoria @florezlab.bsky.social @danafarber.bsky.social @danafarbernews.bsky.social @younglungcancer.bsky.social @oncodaily.bsky.social
011
Reposted by Narjust Florez, MD, FASCO
Florez Lab @florezlab.bsky.social · 20/03/2025
Stocked up and ready to get back to packing up more #HearHer orders #HearHerHustle #ReadySetPack @younglungcancer.bsky.social @narjustflorezmd.bsky.social
021
Reposted by Narjust Florez, MD, FASCO
IASLC @iaslc.bsky.social · 20/03/2025
🎙️ Don't miss this all-new episode of #LungCancerConsidered! Host @stephenvliu.bsky.social continues our #VirtualTumorBoard series with a complex Stage III ALK+ #NSCLC case. How should clinicians approach this patient? Listen now for expert insights! 🎧 bit.ly/VTBsIIIALK #ALKPositive #IASLC
bit.ly
Virtual Tumor Board: Stage III ALK+ NSCLC | IASLC
This IASLC Virtual Tumor Board episode focuses on a patient with stage III ALK-positive NSCLC. ALK fusions are present in about 5% of NSCLC and there are now si ...
052
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 20/03/2025
With some many conversations about lung cancer in young women, I invite you revisit our editorial in @ASCO Connections early this year where we discussed the #HearHer campaign connection.asco.org/do/hearher-c...
031
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 15/03/2025
Love walking in the hallways of my floor and hearing so many different languages … You gotta love Revere Beach
000
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 15/03/2025
No better to start your Saturday morning than Fania and Coffee! Wepale! Sound on mami 🎶
000
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 14/03/2025
Some pieces age well & sadly remain true “Please don’t tell my family” was one of my first @ASCO Connection narrative piece “Mary” changed my career pathway and opened my eyes to lung cancer stigma connection.asco.org/do/helping-p...
connection.asco.org
“Please Don’t Tell My Family!”: Helping Patients Face Lung Cancer Stigma
Dr. Narjust Duma treated a patient who was brave in the face of lung cancer, but feared the judgment of her community.
021
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 12/03/2025
Lucky to work with this amazing lady Dr. Ugalde at @DFarberThoracic - together we hold the higher number of pCR cases - from adjuvant ALK to the first Checkmate816 protocol case after approval
080
Reposted by Narjust Florez, MD, FASCO
OncoDaily @oncodaily.bsky.social · 09/03/2025
IASLC - The Benefits of Patient Advocacy Groups @iaslc.bsky.social @narjustflorezmd.bsky.social @sunonmyhip.bsky.social oncodaily.com/blog/patient... #Cancer #CancerAwareness #LungCancer #IASLC #LungCancerAwareness #CancerSurvivor #Medicine #Health #Oncology #OncoDaily
oncodaily.com
The Benefits of Patient Advocacy Groups - IASLC - OncoDaily
The Benefits of Patient Advocacy Groups - IASLC / cancer, IASLC, International Association for the Study of Lung Cancer, Narjust Florez, OncoDaily, Oncology,
092
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 09/03/2025
A moment of zen
010
Narjust Florez, MD, FASCO @narjustflorezmd.bsky.social · 08/03/2025
With my new friend from Puerto Rico She agrees we need to #HearHer
000